Ventas Company Profile (NYSE:VTR)

About Ventas (NYSE:VTR)

Ventas, Inc. is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses. In its senior living operations segment, it invests in seniors housing communities throughout the United States and Canada and engages independent operators to manage those communities. In its office operations segment, the Company primarily acquires, owns, develops, leases and manages medical office buildings (MOBs) and life science and innovation centers throughout the United States.

Industry, Sector and Symbol:

Sector: Finance
Industry: Healthcare REITs
Sub-Industry: Specialized REITs
Symbol: NYSE:VTR
CUSIP: 92276F10
Web: www.ventasreit.com

Capitalization:

Market Cap: $24.14917 billion
Outstanding Shares: 354,873,000

Average Prices:

50 Day Moving Avg: $68.76
200 Day Moving Avg: $64.88
52 Week Range: $56.20 - $76.80

P/E:

Trailing P/E Ratio: 34.484
Foreward P/E Ratio: 15.75
P/E Growth: 5.440

Sales & Book Value:

Annual Revenue: $3.48 billion
Price / Sales: 6.92
Book Value: $29.35 per share
Price / Book: 2.31

Dividend:

Annual Dividend: $3.10
Dividend Yield: 4.6%

Profitability:

EBIDTA: $1.85 billion
Net Margins: 20.10%
Return on Equity: 6.34%
Return on Assets: 2.83%

Debt:

Debt-to-Equity Ratio: 1.14%
Current Ratio: 1.54%
Quick Ratio: 1.54%

Misc:

Average Volume: 1.71 million shs.
Beta: 0.08
Short Ratio: 4.44

Frequently Asked Questions for Ventas (NYSE:VTR)

What is Ventas' stock symbol?

Ventas trades on the New York Stock Exchange (NYSE) under the ticker symbol "VTR."

How often does Ventas pay dividends? What is the dividend yield for Ventas?

Ventas announced a quarterly dividend on Thursday, May 18th. Stockholders of record on Tuesday, June 6th will be paid a dividend of $0.775 per share on Friday, June 30th. This represents a $3.10 annualized dividend and a dividend yield of 4.57%. The ex-dividend date is Friday, June 2nd. View Ventas' Dividend History.

How were Ventas' earnings last quarter?

Ventas, Inc. (NYSE:VTR) issued its quarterly earnings results on Friday, April, 28th. The company reported $0.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.02 by $0.58. The company had revenue of $883.44 million for the quarter, compared to the consensus estimate of $873.56 million. Ventas had a net margin of 20.10% and a return on equity of 6.34%. The company's quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.04 earnings per share. View Ventas' Earnings History.

When will Ventas make its next earnings announcement?

Ventas is scheduled to release their next quarterly earnings announcement on Friday, July, 28th 2017. View Earnings Estimates for Ventas.

What guidance has Ventas issued on next quarter's earnings?

Ventas updated its FY17 earnings guidance on Friday, April, 28th. The company provided EPS guidance of $4.12-4.18 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.15.

Where is Ventas' stock going? Where will Ventas' stock price be in 2017?

12 brokers have issued 12 month target prices for Ventas' stock. Their forecasts range from $56.00 to $75.00. On average, they anticipate Ventas' share price to reach $64.14 in the next twelve months. View Analyst Ratings for Ventas.

Who are some of Ventas' key competitors?

Some companies that are related to Ventas include Welltower (HCN), HCP (HCP), Omega Healthcare Investors (OHI), Medical Properties Trust (MPW), Healthcare Trust of America (HTA), Healthcare Realty Trust Incorporated (HR), Physicians Realty Trust (DOC), National Health Investors (NHI), Care Capital Properties (CCP), LTC Properties (LTC), Sabra Healthcare REIT (SBRA), CareTrust REIT (CTRE), Assura PLC (AGR), Primary Health Properties PLC (PHP), MedEquities Realty Trust (MRT), Community Healthcare Trust Incorporated (CHCT), Aviv REIT (AVIV) and Global Medical REIT (GMRE).

Who are Ventas' key executives?

Ventas' management team includes the folowing people:

Debra A. Cafaro, Chairman of the Board, Chief Executive Officer
Robert F. Probst, Chief Financial Officer, Executive Vice President
T. Richard Richard Riney, Executive Vice President, Chief Administrative Officer, General Counsel
John D. Cobb, Executive Vice President, Chief Investment Officer
Todd W. Lillibridge, EVP - Medical Property Operations; President and CEO of Lillibridge Healthcare Services Inc
Melody C. Barnes, Independent Director
Jay M. Gellert, Independent Director
Richard I. Gilchrist, Independent Director
Matthew J. Lustig, Independent Director
Roxanne M. Martino, Independent Director

Who owns Ventas stock?

Ventas' stock is owned by many different of institutional and retail investors. Top institutional shareholders include APG Asset Management US Inc. (4.03%), PGGM Investments (0.54%), Hexavest Inc. (0.29%), Russell Investments Group Ltd. (0.25%), NN Investment Partners Holdings N.V. (0.18%) and Miller Howard Investments Inc. NY (0.14%). Company insiders that own Ventas stock include Debra A Cafaro, Douglas Crocker II, Gregory R Liebbe, John D Cobb and T Richard Riney. View Institutional Ownership Trends for Ventas.

Who sold Ventas stock? Who is selling Ventas stock?

Ventas' stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Sumitomo Mitsui Asset Management Company LTD, Oregon Public Employees Retirement Fund, Hexavest Inc., Gateway Investment Advisers LLC, State of Alaska Department of Revenue, Nisa Investment Advisors LLC and Exxonmobil Investment Management Inc. TX. Company insiders that have sold Ventas stock in the last year include Debra A Cafaro, Gregory R Liebbe, John D Cobb and T Richard Riney. View Insider Buying and Selling for Ventas.

Who bought Ventas stock? Who is buying Ventas stock?

Ventas' stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., APG Asset Management US Inc., Forsta AP Fonden, Mn Services Vermogensbeheer B.V., Doyle Wealth Management, NN Investment Partners Holdings N.V., National Pension Service and PGGM Investments. View Insider Buying and Selling for Ventas.

How do I buy Ventas stock?

Shares of Ventas can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ventas' stock price today?

One share of Ventas stock can currently be purchased for approximately $67.90.

MarketBeat Community Rating for Ventas (NYSE VTR)

Community Ranking:		1.7 out of 5 ()
Outperform Votes:		192 (Vote Outperform)
Underperform Votes:		366 (Vote Underperform)
Total Votes:		558

MarketBeat's community ratings are surveys of what our community members think about Ventas and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Ventas (NYSE:VTR) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	3 Sell Ratings, 9 Hold Ratings
Consensus Rating:	Hold (Score: 1.75)
Consensus Price Target:	$64.14 (5.53% downside)

Analysts' Ratings History for Ventas (NYSE:VTR)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
6/28/2017	Mizuho	Reiterated Rating	Neutral		Low
6/21/2017	Mitsubishi UFJ Financial Group	Initiated Coverage	Hold	$67.00	Low
5/1/2017	Jefferies Group LLC	Boost Price Target	Hold	$61.00 -> $64.00	Low
4/12/2017	BMO Capital Markets	Reiterated Rating	Sell	$60.00	Low
3/21/2017	SunTrust Banks, Inc.	Initiated Coverage	Hold	$64.00	High
3/15/2017	Goldman Sachs Group, Inc. (The)	Downgrade	Neutral -> Sell	$56.00	Medium
3/3/2017	Evercore ISI	Downgrade	Hold -> Underperform		N/A
11/11/2016	Hilliard Lyons	Upgrade	Underperform -> Neutral		N/A
8/29/2016	Argus	Reiterated Rating	Hold		N/A
8/25/2016	BTIG Research	Initiated Coverage	Neutral		N/A
8/8/2016	Citigroup Inc.	Boost Price Target	Neutral	$70.00 -> $75.00	N/A
7/26/2016	Raymond James Financial, Inc.	Initiated Coverage	Market Perform		N/A
7/7/2016	Barclays PLC	Reiterated Rating	Hold	$64.00	N/A
5/12/2016	Deutsche Bank AG	Boost Price Target	Hold	$56.00 -> $58.00	N/A
3/3/2016	Piper Jaffray Companies	Upgrade	Neutral -> Overweight		N/A
2/17/2016	Royal Bank Of Canada	Lower Price Target	Outperform	$70.00 -> $62.00	N/A
2/16/2016	Stifel Nicolaus	Downgrade	Buy -> Hold		N/A
9/14/2015	KeyCorp	Lower Price Target		$58.00 -> $45.00	N/A
9/8/2015	Evercore Partners Inc	Lower Price Target	Buy	$65.00 -> $61.00	N/A

(Data available from 7/26/2015 forward)

Earnings History for Ventas (NYSE:VTR)

Earnings by Quarter for Ventas (NYSE:VTR)

Earnings History by Quarter for Ventas (NYSE VTR)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/28/2017		$0.45					N/A
4/28/2017	Q1 17	$1.02	$0.44	$873.56 million	$883.44 million	View	N/A
2/10/2017	Q416	$1.02	$1.03	$843.40 million	$875.71 million	View	Listen
10/28/2016	Q316	$1.01	$1.03	$842.66 million	$867.12 million	View	Listen
7/29/2016	Q216	$1.04	$1.04	$845.40 million	$848.50 million	View	Listen
4/29/2016	Q116	$1.03	$1.04	$833.89 million	$852.30 million	View	Listen
2/12/2016	Q415	$1.01	$1.03	$810.05 million	$841.30 million	View	Listen
10/23/2015	Q315	$1.08	$1.09	$836.04 million	$827.60 million	View	Listen
7/24/2015	Q215	$1.16	$1.18	$871.22 million	$891.30 million	View	Listen
4/24/2015	Q115	$1.14	$1.18	$855.06 million	$884.02 million	View	Listen
2/13/2015	Q414	$1.12	$1.15	$783.95 million	$803.99 million	View	Listen
10/24/2014	Q314	$1.11	$1.12	$749.00 million	$779.00 million	View	Listen
8/11/2014	Q214	$1.09	$1.09	$741.08 million	$751.25 million	View	Listen
4/25/2014	Q114	$1.07	$1.09	$725.56 million	$741.50 million	View	Listen
2/14/2014	Q413	$1.06	$1.06	$706.39 million	$732.86 million	View	Listen
10/25/2013	Q313	$1.02	$1.04	$680.72 million	$712.39 million	View	Listen
7/26/2013	Q213	$1.01	$1.01	$677.71 million	$685.85 million	View	Listen
4/26/2013	Q113	$1.00	$1.03	$662.56 million	$384.87 million	View	Listen
2/15/2013	Q412	$0.97	$0.99	$644.71 million	$660.71 million	View	Listen
10/26/2012	Q312	$0.94	$0.96	$629.80 million	$641.95 million	View	N/A
7/26/2012		$0.91	$0.95			View	N/A
4/27/2012		$0.89	$0.91			View	N/A
11/4/2011		$0.82	$0.88			View	N/A
8/4/2011		$0.76	$0.80			View	N/A
5/5/2011		$0.74	$0.75			View	N/A
2/17/2011		$0.75	$0.77			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Ventas (NYSE:VTR)

2017 EPS Consensus Estimate: $4.16

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	2	$1.01	$1.02	$1.02
Q2 2017	2	$1.04	$1.04	$1.04
Q3 2017	2	$1.05	$1.05	$1.05
Q4 2017	2	$1.05	$1.05	$1.05

(Data provided by Zacks Investment Research)

Current Dividend Information for Ventas (NYSE:VTR)

Most Recent Dividend:	6/30/2017
Annual Dividend:	$3.10
Dividend Yield:	4.57%
Dividend Growth:	2.70% (3 Year Average)
Payout Ratio:	157.36% (Trailing 12 Months of Earnings) 74.34% (Based on This Year's Estimates) 71.93% (Based on Next Year's Estimates)
Track Record:	6 Years of Consecutive Dividend Growth

Dividend Payments by Quarter for Ventas (NYSE:VTR)

Dividend History by Quarter for Ventas (NYSE VTR)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/18/2017	quarterly	$0.78	4.62%	6/2/2017	6/6/2017	6/30/2017
2/10/2017	quarterly	$0.78	5.03%	3/3/2017	3/7/2017	3/31/2017
12/8/2016	quarterly	$0.78	4.96%	12/16/2016	12/20/2016	12/30/2016
8/29/2016	quarterly	$0.73	3.99%	9/13/2016	9/15/2016	9/30/2016
5/11/2016	quarterly	$0.73	4.45%	6/2/2016	6/6/2016	6/30/2016
2/12/2016	quarterly	$0.73	5.87%	3/3/2016	3/7/2016	3/31/2016
12/11/2015	quarterly	$0.73	5.36%	12/17/2015	12/21/2015	12/30/2015
9/3/2015	quarterly	$0.73	5.36%	9/11/2015	9/15/2015	9/30/2015
5/14/2015	quarterly	$0.79		6/3/2015	6/5/2015	6/30/2015
2/19/2015	special	$0.58	4.14%	3/4/2015	3/6/2015	3/31/2015
12/10/2014	quarterly	$0.79	4.29%	12/10/2014	12/22/2014	12/31/2014
9/2/2014	quarterly	$0.73	4.39%	9/10/2014	9/12/2014	9/30/2014
5/15/2014	quarterly	$0.73	4.25%	6/4/2014	6/6/2014	6/27/2014
2/14/2014	quarterly	$0.73	4.72%	3/5/2014	3/7/2014	3/28/2014
12/9/2013	quarterly	$0.73	5%	12/12/2013	12/16/2013	12/31/2013
12/9/2013		$0.73		12/12/2013	12/16/2013	12/31/2013
9/3/2013	quarterly	$0.67	4.34%	9/11/2013	9/13/2013	9/27/2013
5/17/2013	quarterly	$0.67	3.28%	6/3/2013	6/5/2013	6/28/2013
2/19/2013	quarterly	$0.67	3.86%	3/6/2013	3/8/2013	3/28/2013
12/6/2012	quarterly	$0.62			12/17/2012	12/28/2012
12/9/2012	quarterly	$0.62	3.8%	12/13/2012	12/17/2012	12/28/2012

(Data available from 1/1/2013 forward)

Insider Trading and Institutional Ownership History for Ventas (NYSE:VTR)

Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 89.15%

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Insider Trades by Quarter for Ventas (NYSE:VTR)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/15/2017	Debra A Cafaro	Chairman	Sell	100,000	$69.12	$6,912,000.00
8/19/2016	Gregory R Liebbe	SVP	Sell	6,943	$73.20	$508,227.60
8/17/2016	T Richard Riney	EVP	Sell	169,450	$72.98	$12,366,461.00
8/2/2016	John D Cobb	EVP	Sell	60,000	$75.05	$4,503,000.00
3/30/2016	Douglas Crocker II	Director	Sell	5,940	$62.91	$373,685.40
1/27/2016	John D. Cobb	EVP	Sell	2,700	$55.66	$150,282.00
1/13/2015	Debra A Cafaro	CEO	Sell	7,919	$77.00	$609,763.00
1/12/2015	Debra A Cafaro	CEO	Sell	9,848	$77.01	$758,394.48
1/9/2015	Debra A Cafaro	CEO	Sell	10,000	$76.17	$761,700.00
1/6/2015	Debra A Cafaro	CEO	Sell	70,193	$75.13	$5,273,600.09
12/12/2014	Debra A Cafaro	CEO	Sell	77,659	$75.05	$5,828,307.95
12/2/2014	Debra A Cafaro	CEO	Sell	142,854	$72.52	$10,359,772.08
12/1/2014	Debra A Cafaro	CEO	Sell	29,872	$72.52	$2,166,317.44
11/25/2014	Debra A Cafaro	CEO	Sell	142,854	$70.12	$10,016,922.48
11/3/2014	Debra A Cafaro	CEO	Sell	89,246	$68.53	$6,116,028.38
6/10/2014	Ronald G Geary	Director	Sell	3,170	$63.97	$202,784.90
12/10/2013	Douglas Crocker II	Director	Buy	10,000	$58.01	$580,100.00
11/12/2012	T Richard Riney	EVP	Sell	52,535	$63.78	$3,350,682.30

(Data available from 1/1/2013 forward)

Headline Trends for Ventas (NYSE:VTR) Latest Headlines for Ventas (NYSE:VTR)

Source:

Date	Headline
	Ventas, Inc. breached its 50 day moving average in a Bearish Manner : VTR-US : July 25, 2017 finance.yahoo.com - July 26 at 9:51 AM
	ETFs with exposure to Ventas, Inc. : July 25, 2017 finance.yahoo.com - July 26 at 9:51 AM
	Ventas (VTR) to Report Q2 Earnings: What's in the Cards? finance.yahoo.com - July 25 at 8:23 AM
	$878.82 Million in Sales Expected for Ventas, Inc. (VTR) This Quarter www.americanbankingnews.com - July 21 at 1:14 PM
	Ventas, Inc. (NYSE:VTR) Set to Announce Earnings on Friday www.americanbankingnews.com - July 21 at 7:06 AM
	Brokerages Expect Ventas, Inc. (VTR) to Announce $1.05 Earnings Per Share www.americanbankingnews.com - July 19 at 10:08 PM
	How Does Wall Street Rate Welltower among Healthcare REITs? finance.yahoo.com - July 19 at 9:16 AM
	Ventas, Inc. (VTR) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - July 18 at 12:48 AM
	Ventas, Inc. Forecasted to Post FY2018 Earnings of $4.30 Per Share (NYSE:VTR) www.americanbankingnews.com - July 17 at 10:57 AM
	ETFs with exposure to Ventas, Inc. : July 14, 2017 finance.yahoo.com - July 15 at 9:31 AM
	Ventas, Inc. breached its 50 day moving average in a Bearish Manner : VTR-US : July 11, 2017 finance.yahoo.com - July 11 at 9:27 AM
	BidaskClub Lowers Ventas, Inc. (VTR) to Buy www.americanbankingnews.com - July 8 at 3:29 PM
	Ventas Announces Second Quarter 2017 Earnings Release Date and Conference Call finance.yahoo.com - July 6 at 5:16 PM
	Kindred Sells Skilled Nursing Facility Business for $700M finance.yahoo.com - July 5 at 11:25 AM
	Financial Comparison: Ventas (NYSE:VTR) & Geo Group Inc (The) (GEO) www.americanbankingnews.com - July 4 at 8:24 AM
	Ventas, Inc. (VTR) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - June 28 at 3:14 PM
	Mizuho Reaffirms Neutral Rating for Ventas, Inc. (VTR) www.americanbankingnews.com - June 28 at 1:50 PM
	Ventas, Inc. (VTR) Expected to Announce Quarterly Sales of $878.82 Million www.americanbankingnews.com - June 25 at 8:12 AM
	Zacks: Brokerages Anticipate Ventas, Inc. (VTR) Will Post Earnings of $1.05 Per Share www.americanbankingnews.com - June 23 at 8:36 PM
	YieldBoost Ventas To 10.7% Using Options www.nasdaq.com - June 22 at 2:39 PM
	Ventas: The Next Lake House Buy seekingalpha.com - June 22 at 2:39 PM
	Mitsubishi UFJ Financial Group Initiates Coverage on Ventas, Inc. (VTR) www.americanbankingnews.com - June 22 at 12:34 AM
	CareTrust REIT (CTRE) & Ventas (VTR) Financial Comparison www.americanbankingnews.com - June 22 at 12:20 AM
	Ventas, Inc. (VTR) Given Average Recommendation of "Hold" by Analysts www.americanbankingnews.com - June 21 at 12:38 AM
	Ventas Seems To Be Well Positioned For The Death Of Obamacare - Bullish seekingalpha.com - June 20 at 9:10 AM
	Ventas, Inc. (VTR) Chairman Debra A. Cafaro Sells 100,000 Shares www.americanbankingnews.com - June 19 at 7:20 PM
	If You Like Boring, You'll Love This REIT seekingalpha.com - June 19 at 8:25 AM
	Ventas, Inc. (VTR) Lifted to Buy at BidaskClub www.americanbankingnews.com - June 17 at 3:32 PM
	Comparing Ventas (VTR) and Omega Healthcare Investors (OHI) www.americanbankingnews.com - June 17 at 12:14 PM
	Critical Comparison: Ventas (VTR) versus Physicians Realty Trust (DOC) www.americanbankingnews.com - June 14 at 10:32 PM
	Ventas to Gain from Life Science Real Estate Investments finance.yahoo.com - June 14 at 1:49 AM
	S&P 500 company says new East End office space 'takes us into a new dynamic' www.bizjournals.com - June 12 at 8:02 PM
	Ventas to Participate in NAREIT REITWeek 2017 Conference finance.yahoo.com - June 7 at 12:53 AM
	Ventas, Inc. : VTR-US: Dividend Analysis : June 06th, 2017 (record date) : By the numbers : June 5, 2017 finance.yahoo.com - June 6 at 1:54 AM
	Ventas, Inc. (VTR) Expected to Post Quarterly Sales of $878.82 Million www.americanbankingnews.com - June 1 at 10:50 AM
	Why Is Ventas (VTR) Up 3.8% Since the Last Earnings Report? finance.yahoo.com - May 31 at 11:39 AM
	Ventas, Inc. (VTR) Expected to Announce Earnings of $1.05 Per Share www.americanbankingnews.com - May 30 at 2:08 PM
	Ventas, Inc. (VTR) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - May 27 at 12:46 AM
	Ventas Prices Cdn$275 Million of 2.55% Senior Notes Due 2023 finance.yahoo.com - May 26 at 8:32 AM
	Ventas Declares Regular Quarterly Dividend of $0.775 Per Share finance.yahoo.com - May 19 at 1:40 PM
	Ventas, Inc. (VTR) Plans $0.78 Quarterly Dividend www.americanbankingnews.com - May 18 at 8:38 PM
	Research Reports Coverage on REIT Stocks -- Ventas, Senior Housing Properties Trust, Healthcare Trust of America, and Quality Care Properties www.bizjournals.com - May 18 at 10:06 AM
	Ventas (VTR) Shares Cross Above 200 DMA www.nasdaq.com - May 12 at 3:31 PM
	$1.05 Earnings Per Share Expected for Ventas, Inc. (VTR) This Quarter www.americanbankingnews.com - May 4 at 10:52 PM
	Ventas, Inc. breached its 50 day moving average in a Bearish Manner : VTR-US : May 4, 2017 finance.yahoo.com - May 4 at 9:45 AM
	Ventas (VTR) Earns Daily Coverage Optimism Rating of 0.12 www.americanbankingnews.com - May 3 at 8:06 PM
	FY2017 EPS Estimates for Ventas, Inc. (VTR) Boosted by Jefferies Group www.americanbankingnews.com - May 3 at 12:48 PM
	The biggest $4B company you never heard of — just got bigger www.bizjournals.com - May 3 at 9:50 AM
	Q2 2017 Earnings Estimate for Ventas, Inc. (VTR) Issued By Jefferies Group www.americanbankingnews.com - May 2 at 8:08 AM
	Ventas, Inc. (VTR) Receives Average Recommendation of "Hold" from Analysts www.americanbankingnews.com - May 2 at 12:28 AM